Structure Therapeutics Inc. American Depositary Shares — Chart, Price & News (NASDAQ:GPCR) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Market Capitalization 3.7667 B
Employee 220
Founded 2016
CEO N/A
Website www.structuretx.com
Headquarter Cayman Islands
FIGI BBG01CBVHLW1
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

3.77 B Market capitalization

Haberler

Structure Therapeutics, Matthew Lang’ı COO ve hukuk müşaviri seçti

Does NVO Face Rising Competitive Pressure on LLY's Foundayo Approval?

Structure Therapeutics: The Oral Obesity Inflection, Best-In-Class Efficacy

Structure Therapeutics: A High-Risk, High-Reward Bet On The Next GLP-1 Blockbuster (GPCR)

Wolfe Research, Structure Therapeutics hissesine Peerperform notu verdi

NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now?

Eli Lilly's Experimental Drug Retatrutide Delivers Strong Weight Loss In Late-Stage Trial

Why Did Eli Lilly Stock Slide 6% Despite Strong GLP-1 Momentum?

BMO raises Structure Therapeutics stock price target on obesity drug data

Structure Therapeutics' GLP-1 Agonist Could Be A Potential Acquisition Target (GPCR)

H.C. Wainwright, Structure Therapeutics için hedef fiyatı düşürdü

H.C. Wainwright lowers Structure Therapeutics price target on penetration assumptions